Pharmacotherapy of acute lung injury and acute respiratory distress syndrome
about
Statins for the prevention and treatment of acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysisPediatric Acute Respiratory Distress Syndrome: Fibrosis versus RepairPharmacological treatments in ARDS; a state-of-the-art updateSurfactant therapy for acute lung injury and acute respiratory distress syndrome.Rediscovering the Schulze-Hardy rule in competitive adsorption to an air-water interfaceThe Src family tyrosine kinases src and yes have differential effects on inflammation-induced apoptosis in human pulmonary microvascular endothelial cells.Dual Effect of low-level laser therapy (LLLT) on the acute lung inflammation induced by intestinal ischemia and reperfusion: Action on anti- and pro-inflammatory cytokines.The NS1 glycoprotein can generate dramatic antibody-enhanced dengue viral replication in normal out-bred mice resulting in lethal multi-organ disease.Rosuvastatin for sepsis-associated acute respiratory distress syndromeKeratinocyte growth factor gene delivery via mesenchymal stem cells protects against lipopolysaccharide-induced acute lung injury in mice.Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study.Synthesis and activity of a novel diether phosphonoglycerol in phospholipase-resistant synthetic lipid:peptide lung surfactants()Dietary Apigenin Exerts Immune-Regulatory Activity in Vivo by Reducing NF-κB Activity, Halting Leukocyte Infiltration and Restoring Normal Metabolic Function.Lung contusion: inflammatory mechanisms and interaction with other injuries.Competitive adsorption: a physical model for lung surfactant inactivation.The protective role of MnTBAP in oxidant-mediated injury and inflammation in a rat model of lung contusion.Year in review 2008: Critical Care--respirology.Specialized enteral formulas in acute and chronic pulmonary disease.Gene therapy for ALI/ARDS.Role of airway recruitment and derecruitment in lung injury.Emerging drugs for acute lung injury.Synthesis, toxicity study and anti-inflammatory effect of MHTP, a new tetrahydroisoquinoline alkaloid.Treatments for Pulmonary Ricin Intoxication: Current Aspects and Future Prospects.Rescue strategies for refractory hypoxemia: a critical appraisal.The impact of pretreatment with bolus dose of enteral glutamine on acute lung injury induced by oleic acid in rats.Peripheral leukocytapheresis attenuates acute lung injury induced by lipopolysaccharide in vivo.Preventive effects of dexmedetomidine on the liver in a rat model of acid-induced acute lung injury.Role of Quzhou Fructus Aurantii Extract in Preventing and Treating Acute Lung Injury and Inflammation.Effects of SDF-1/CXCR4 on Acute Lung Injury Induced by Cardiopulmonary Bypass.Absinthin attenuates LPS-induced ALI through MIP-1α-mediated inflammatory cell infiltration.
P2860
Q26746082-44EC49D0-2C3F-4FB5-81C2-FAF1A4C5F009Q26749366-11F97AA5-FDC2-4294-8CBA-BE02E911FADFQ27022850-4F4E8FBA-4491-4E93-8D48-2D61F3A86BDBQ30426177-364ADDF4-DE3E-4DCA-8F7F-D416457D373BQ30489870-6B8AE925-2387-4C6A-98C3-215DFE3CD572Q33891383-17F11FB5-DF1F-4953-AEB1-580A074739CAQ33933275-E984ED22-E4B3-4B5E-A6FC-61BEA595416EQ33952146-C20B716B-33F6-47DE-B80E-2D0BEC644BACQ34559446-F5B369B4-26DB-42FC-91EA-8DD8FEDE5DAAQ35075538-7006FC84-D83B-4688-B08C-187AFC840FBEQ35649119-9E70EC70-0890-4039-A779-2C4879564DCCQ35902753-E4D55332-CEC8-4FC0-BBBA-771A0C987AA0Q36743584-2BF97AA0-2706-4860-B018-8B360635E6CAQ37265163-AEAF849E-CB1D-4E47-9569-713193264F3DQ37320766-57335807-8CCB-4A5D-A474-4F47EF0B4E88Q37373482-F486AC73-71BE-4731-9B56-BB91DB3FD728Q37623070-74CD3A6D-7EBF-4947-90A4-FA912FE2CB0DQ37643137-C1317526-368D-4DDB-A148-FA221499C1C8Q37899551-9AE55100-EB4D-41AE-BBF8-B55CEAD1F5D2Q37947390-C885E83B-B5A4-4B93-8128-588BED9DC878Q38308143-48F9BEF7-CB54-44D9-A5D0-00A288060088Q38981137-BA334976-DA8B-495A-87DD-8A29C437CF5EQ41991679-581C8094-374A-4724-A564-A5A65CA7BB39Q42415598-E1BBAD56-4E12-47D3-976B-1BEDCDC963B2Q42449820-E4AB153A-BE74-4C17-8973-0C04EB56C612Q42560678-8A9E5B22-5E26-4461-890D-D03783EEA2CBQ42820143-2AFB2E91-0336-4D87-9964-8A11BB8D512DQ47646271-09C9CEF9-55FB-496A-8BDA-786B9D6DDCCAQ50849012-1EBFB5FC-EAF4-4171-921A-ACBA4D5CAE72Q50920685-363F8F78-13C9-4225-81FC-6787FC123714
P2860
Pharmacotherapy of acute lung injury and acute respiratory distress syndrome
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacotherapy of acute lung injury and acute respiratory distress syndrome
@en
Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.
@nl
type
label
Pharmacotherapy of acute lung injury and acute respiratory distress syndrome
@en
Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.
@nl
prefLabel
Pharmacotherapy of acute lung injury and acute respiratory distress syndrome
@en
Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.
@nl
P2093
P2860
P1476
Pharmacotherapy of acute lung injury and acute respiratory distress syndrome
@en
P2093
Bruce A Davidson
Gloria S Pryhuber
Krishnan Raghavendran
Patricia R Chess
Paul R Knight
Robert H Notter
P2860
P304
P356
10.2174/092986708785132942
P577
2008-01-01T00:00:00Z